Several miRNAs, such as miR-145 and miR-497, have been shown to target IGF-1R and downregulate its expression, thereby inhibiting IGF-1 signaling and reducing BC cell proliferation and invasion [110,111]. The gene discussed is IGF1; the disease is breast cancer.